Metastatic renal cell carcinoma patients of T4 stage who are in status of N1 stage or older than 76 years cannot benefit from cytoreductive nephrectomy | BMC Cancer | Full Text

Metastatic renal cell carcinoma patients of T4 stage who are in status of N1 stage or older than 76 years cannot benefit from cytoreductive nephrectomy | BMC Cancer | Full Text

Metastatic renal cell carcinoma patients of T4 stage who are in status of N1 stage or older than 76 years cannot benefit from cytoreductive nephrectomy

We aimed to identify which part of the patients with metastatic renal cell carcinoma (mRCC) is not suitable for cytoreductive nephrectomy (CN).

Authors:Zhao Zhang, Hongliang Wu, Tong Yang, Yaohai Wu, Nengwang Yu and Zhonghua Xu

Citation:BMC Cancer 2020 20:844

Content type:Research article

 

Published on: 3 September 2020

• ViewFull Text
 
• ViewPDF